1. Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal 2012;2012:756357. [DOI:10.1100/2012/756357]

2. Prince M, Albanese E, Guerchet M, Prina M. World Alzheimer Report 2014: dementia and risk reduction: an analysis of protective and modifiable factors. Alzheimer's Disease International 2014.

3. Alzheimer's Association. 2015 Alzheimer's disease facts and figures. Alzheimer's & dementia: J Alzheimers Dis 2015;11:332-84. [DOI:10.1016/j.jalz.2015.02.003]

4. Querfurth HW, LaFerla FM. Mechanisms of disease. N Engl J Med 2010; 362:329-44. [DOI:10.1056/NEJMra0909142]

5. Schmid AW, Lynch MA, Herron CE. The effects of IL‐1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo. Hippocampus 2009; 19:670-76. [DOI:10.1002/hipo.20542]

6. Su F, Bai F, Zhang Z. Inflammatory cytokines and Alzheimer's disease: a review from the perspective of genetic polymorphisms. Neurosci Bull 2016; 32:469-80. [DOI:10.1007/s12264-016-0055-4]

7. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21:383-421. [DOI:10.1016/S0197-4580(00)00124-X]

8. Rao PP, Kabir SN, Mohamed T. Nonsteroidal anti-inflammatory drugs (NSAIDs): progress in small molecule drug development. Pharmaceuticals (Basel) 2010;3:1530-49. [DOI:10.3390/ph3051530]

9. Anand R, Gill KD, Mahdi AA. Therapeutics of Alzheimer's disease: Past, present and future. Neuropharmacology 2014;76:27-50. [DOI:10.1016/j.neuropharm.2013.07.004]

10. Alzheimer's Association. 2014 Alzheimer's disease facts and figures. Alzheimer's & dementia: J Alzheimers Dis 2014;10:e47-92. [DOI:10.1016/j.jalz.2014.02.001]

11. Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 2002;68:209-45. [DOI:10.1016/S0301-0082(02)00079-5]

12. Farlow MR, Miller ML, Pejovic V. Treatment options in Alzheimer's disease: maximizing benefit, managing expectations. Dement Geriatr Cogn Disord 2008; 25:408-22. [DOI:10.1159/000122962]

13. Simunkova M, Alwasel SH, Alhazza IM, Jomova K, Kollar V, Rusko M,et al. Management of oxidative stress and other pathologies in Alzheimer's disease. Arch Toxicol 2019; 22:1-23. [DOI:10.1007/s00204-019-02538-y]

14. Ha GT, Wong RK, Zhang Y. Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies. Chem Biodivers 2011;8:1189-204. [DOI:10.1002/cbdv.201000269]

15. Polinsky RJ. Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Clin Ther 1998;20:634-47. [DOI:10.1016/S0149-2918(98)80127-6]

16. Bemanian MH, Farhoudi A, Pourpak Z, Gharagozlou M, Movahedi M, Nabavi M, et al. Systemic and local reactions of bee venom immunotherapy in Iran. Iranian Journal of Allergy, Asthma and Immunology (IJAAI) 2007;6:203-6.

17. Borrelli F, Maffia P, Pinto L, Ianaro A, Russo A, Capasso F, et al. Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia 2002;73:S53-63. [DOI:10.1016/S0367-326X(02)00191-0]

18. Farooqui T, Farooqui AA. Beneficial effects of propolis on human health and neurological diseases. Front Biosci (Elite Ed) 2012;4:779-93. [DOI:10.2741/e418]

19. Lahouel M, B.K, Kebsa W, Alyane M. Polyphenolic fractions of Algerian propolis reverses doxorubicin induced acuterenal oxidative stress. African J Pharm Pharmacology (AJPP). 2010; 4: 712-720.

20. Lindner MD, Hogan JB, Hodges DB Jr, Orie AF, Chen P, Corsa JA, Leet JE, Gillman KW, Rose GM, Jones KM, Gribkoff VK. Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping. Psychopharmacology (Berl) 2006;188:629-40. [DOI:10.1007/s00213-006-0556-3]

21. Cardiff RD, Miller CH, Munn RJ. Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc 2014; 2: 655-8. [DOI:10.1101/pdb.prot073411]

22. Ayikobua ET, Semuyaba I, Eze DE, Kalange M, Nansunga M, Okpanachi AO, et al. Combined Donepezil and Ethanolic Extract of Propolis Improved Memory Better Than Donepezil and Propolis Monotherapy in Wild Type Drosophila melanogaster. Evidence-Based Complementary and Alternative Medicine (eCAM). 2018;2018. [DOI:10.1155/2018/3717328]

23. Nanaware S, Shelar M, Sinnathambi A, Mahadik KR, Lohidasan S. Neuroprotective effect of Indian propolis in β-amyloid induced memory deficit: impact on behavioral and biochemical parameters in rats. Biomed Pharmacother 2017;93:543-53. [DOI:10.1016/j.biopha.2017.06.072]

24. van Gijsel-Bonnello M, Baranger K, Benech P, Rivera S, Khrestchatisky M, de Reggi M, et al. Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: alleviation by pantethine. PloS One 2017;12:e0175369. [DOI:10.1371/journal.pone.0175369]